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Blood Transfusion and Postoperative Infection
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Abstract
Study Design: Systematic review.
Objectives: Allogeneic blood transfusion-related immunomodulation may relatively suppress the immune system, heightening
the risk of infection following spine surgery. This systematic review seeks to determine whether allogeneic blood transfusion
increases the risk of postoperative infection and whether there are any factors that modify this association.
Methods: PubMed, Cochrane Central Register of Controlled Trials, and reference lists from included studies were searched
from inception to April 20, 2017 to identify studies examining the risk of infection following allogeneic blood transfusion in adult
patients receiving surgery for degenerative spine disease.
Results: Eleven retrospective cohort or case-control studies, involving 8428 transfusion patients and 43 242 nontransfusion
patients, were identified as meeting the inclusion criteria. Regarding surgical site infection (SSI), the results were mixed with
roughly half reporting a significant association. There was an association between allogeneic transfusion and urinary tract
infection (UTI) and any infection, but not respiratory tract infection. There was no statistical modifying effect of lumbar
versus thoracic surgery on the association of allogeneic transfusion and SSI, though subgroup analyses in 3 of 4 studies
reported a statistical association between transfusion and postoperative infections, including SSI, UTI, and any infection
within the lumbar spine.
Conclusions: This systematic review failed to find a consistent association between allogeneic transfusion and post-
operative infection in spine surgery patients. However, these studies were all retrospective with a high or moderately high
risk of bias. To properly examine this association an observational prospective study of sufficient power, estimated as 2400
patients, is required.
Keywords
allogeneic blood transfusion, postoperative infection, spine, complications
Introduction
The United States has seen a growing rate of allogeneic blood
transfusion in the context of spine surgery.1,2 Intraoperative
blood loss necessitates the transfusion of allogeneic blood to
avoid perioperative anemia, itself identified as an independent
risk factor in perioperative morbidity and mortality.3,4 How-
ever, there exist consequential trade-offs between the risks and
benefits of allogeneic blood transfusion versus anemia in terms
of their effects on perioperative outcomes.3,4
Although the adverse effects of allogeneic blood transfusion
on postoperative infection in the context of spine surgery have
been demonstrated, the low power and uncontrolled potential
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confounds of many of these studies has limited the interpreta-
tion of their data. The aim of this systematic review is to eval-
uate the association between allogeneic transfusion and
postoperative infection in spine surgery patients, as well as the
many modifying risk factors. We sought to answer the follow-
ing key questions: (1) Does allogeneic blood transfusion
increased the risk of postoperative infection in patients under-
going spine surgery compared with no blood transfusion?
(2) Are there any factors that modify the risk of infection asso-
ciated with allogeneic blood transfusion?
Materials and Methods
Study Design: Systematic Review
Information Sources and Search. PubMed, Cochrane Central Reg-
ister of Controlled Trials, and reference lists from included
studies were searched from inception to April 20, 2017. Search
strategy can be found in the Supplemental Online Material.
Eligibility Criteria
Inclusion criteria. (1) Adult patients receiving surgery for
degenerative spine disease and (2) comparative studies com-
paring the risk of infection in those with allogeneic blood
transfusion versus no blood transfusion.
Exclusion criteria. (1) More than or equal to 20% of patients
who received spine surgery for trauma or cancer, (2) 20% of
patients who received autologous blood instead of allogeneic
blood, (3) outcomes other than infection, and (4) case series.
Data Identification and Extraction. Articles were selected for
inclusion and data was extracted by 2 investigators (CF,
JRD). Discrepancies were resolved through discussion. The
following data items were recorded: study author, study
design, study demographics (sample size, age, sex), data
source, spine segment treated, timing of transfusion, covari-
ates analyzed, odds ratio from both univariate and multi-
variate models comparing infection in those receiving
blood transfusion versus no transfusion.
Outcomes. Surgical site infection, urinary tract infection,
respiratory tract infection, sepsis.
Analysis and Synthesis of Results
Qualitative synthesis and meta-analysis. Because of the like-
lihood of confounding, the primary analysis used adjusted ver-
sus crude odds ratios. For meta-analysis, we performed a
logarithmic transformation of the adjusted odds ratios and con-
fidence intervals. The corresponding standard errors were then
computed. Next the studies were pooled and weighted accord-
ing to the inverse of their respective variances, which were
derived from the standard errors. A random effects model was
assumed. Final values were exponentiated back to and pre-
sented in their original scale. Calculations and figures were
done with RevMan v. 5.2.
Results
Study Selection and Characteristics
We identified 19 of 88 studies as potentially meeting inclusion
criteria. After full-text review of the 19 studies, 8 were
excluded (wrong population, n ¼ 3; wrong comparison, n¼2;
wrong study design, n ¼ 2; and wrong outcome, n ¼ 1)
(Figure 1). Citations and a comprehensive list of reasons for
exclusion can be found in the Supplemental Online Material.
The remaining 11 met inclusion criteria and were retained.
These studies involved 8428 patients who received a transfu-
sion and 43 242 who did not. They are composed of 6 retro-
spective cohort studies5-10 and 5 retrospective case-control
studies.11-15 All studies have moderately high or high risk of
bias, class of evidence (CoE) III or IV (see Supplemental
Online Material for CoE evaluation). Characteristics of the
included studies are summarized in Table 1.
Does allogeneic blood transfusion increase the risk of post-
operative infection in patients undergoing spine surgery com-
pared with no blood transfusion?
Surgical Site Infection. With regard to surgical site infection (SSI),
results from 10 low-quality studies are mixed; 3 studies report a
significant association between allogeneic blood transfusion
and infection,7,8,10 4 report no significant association,12-15
1 study describes an association within certain patient sub-
groups but not in others5 and 2 do not report multivarariate
analysis6,11 (Table 2).
Urinary Tract Infection. Two low-quality studies7,8 found a sig-
nificant association between allogeneic transfusion and urinary
tract infection (UTI), pooled odds ratio 2.4 (95% CI, 1.6-3.5)
(Figure 2).
Respiratory Tract Infection. Two low quality studies7,8 failed to
find an association between allogeneic transfusion and
Figure 1. Study selection.
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respiratory tract infection (RTI), pooled odds ratio 1.5 (95% CI,
1.7-2.9) (Figure 3).
Any Infection. Two low-quality studies assessed the association
between allogeneic blood transfusion and any infection. Any
infection is defined as an SSI, RTI, UTI, sepsis, and Clostridium
difficile in one study by Fisahn et al,6 and SSI, RTI, UTI, endo-
carditis, meningitis, and central venous line infection in a second
study by Janssen et al.7 Pooling the studies result in a significant
association, pooled odds ratio 2.6 (95% CI, 1.8-4.0) (Figure 4).
In-Hospital Infection. One small low-quality study did not
find an association between allogeneic blood transfusion
and in-hospital infection, crude odds ratio, 6.3 (95% CI,
0.6-310).
Are There Any Factors That Modify the Risk of Infection
Associated With Allogeneic Blood Transfusion?
One study stratified SSI results by spine segment, lumbar and
thoracic. There was no statistical difference between the
Table 2. Association (Crude and Adjusted Odds Ratio and 95% Confidence Interval) Between Allogeneic Blood Transfusion and Infection in
Spine Surgery (P Value for Adjusted Odds Ratio Only).
First Author Transfusion Timing Surgery Infection Crude OR (95% CI) Adjusted OR (95% CI) P
Janssen 2015 Periop L þ/ SSI — 2.6 (1.3-5.3) .007
Kato 2016 Periop L þ/ SSI 2.9 (2.5-3.3) 1.9 (1.4-2.5) <.001
Fisahn 2017 Periop Sp þ SSI Not calculable Not calculable
Woods 2013 Intra, postop L þ/ SSI — 1.3 (0.5-2.9) .37
Olsen 08 Periop Sp þ/ SSI 3.4 (1.6-7.3) ns >.05
Apisarnthanarak 2003 Intra, postop Sp þ/ SSI 1.3 (0.3-5.5) —
Maragakis 2009 Periop Sp þ/ SSI 6.7 (3.5-12.7) ns >.05
Olsen 2003 Intra, postop C, L, T, LS þ/ SSI 5.6 (2.6-12.1) ns >.05
Veeravegu 2009 Intraop Sp þ/ SSI 2.1 (1.6-2.8) 1.4 (1.1-1.9) <.05
Aoude 2016
Deep Intra, postop L þ/ SSI 2.8 (1.8-4.4) 2.4 (1.6-3.8) <.001
Superficial Intra, postop L þ/ SSI 1.5 (1.0-2.3) 1.5 (1.03-2.3) <.037
Deep Intra, postop T þ/ SSI 0.5 (0.1-2.7) 0.6 (0.1-3.0) .495
Superficial Intra, postop T þ/ SSI 1.2 (0.4-3.5) 0.9 (0.3-2.8) .914
Janssen 2015 Periop L þ/ Any — 2.6 (1.7-3.9) <.001
Fisahn 2017 Periop Sp þ Any 5.1 (0.9-50.1) 3.5 (0.6-20.9) .172
Janssen 2015 Periop L þ/ UTI — 2.2 (1.3-3.8) .004
Kato 2016 Periop L þ/ UTI — 2.5 (1.5-4.2) <.001
Triulzi 1992 Unknown Sp þ In hospital 6.3 (0.6-310) —
Abbreviations: C, cervical; L, lumbar; LS, lumbosacral; ns, not significant (adjusted OR not reported); OR, odds ratio; T, thoracic; Sp, spinal; SSI, surgical site
infection; UTI, urinary tract infection. þ, with fusion; þ/, with or without fusion.
Figure 2. The association of allogeneic blood transfusion and urinary tract infection in spine surgery.
Figure 3. The association of allogeneic blood transfusion and respiratory tract infection.
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subgroups, P ¼ .10, possibly due to the small sample size and
variability in the thoracic spine (Figure 5). Stratifying the
results of all studies reporting SSI by spinal segment reveals
that allogeneic blood transfusion is significantly associated
with SSI in 3 of 4 studies in surgeries restricted to the lumbar
spine. This is in contrast to only 1 of 5 studies reporting a
significant association in studies of only the thoracic spine or
in studies that likely include several segments (Table 3). The
pattern is similar for UTI and any infection.
Evidence Summary (Table 4)
 Mixed results as to whether allogeneic blood transfusion
is associated with SSI in spine surgery patients, strength
of evidence very low.
 Allogeneic blood transfusion is associated with UTI;
pooled odds ratio 2.4 (95% CI, 1.6-3.5), strength of evi-
dence low.
 No association between allogeneic blood transfusion
and RTI; pooled odds ratio 1.5 (95% CI, 0.7-2.9),
strength of evidence very low.
 Allogeneic blood transfusion is associated with any
infection; pooled odds ratio 2.6 (95% CI, 1.8-4.0),
strength of evidence very low.
 Allogeneic blood transfusion was not significantly asso-
ciated with SSI in a direct comparison when the surgery
was performed in the lumbar spine compared with thor-
acic spine, strength of evidence very low.
Clinical Guidelines
American Association of Blood Banks’ (AABB)
recommendations16:
 Recommendation 1: The AABB recommends a restric-
tive red blood cell (RBC) transfusion threshold in which
the transfusion is not indicated until the hemoglobin
level is 7 g/dL for hospitalized adult patients who are
hemodynamically stable, including critically ill patients,
rather than a liberal threshold when the hemoglobin
level is 10 g/dL (strong recommendation, moderate
quality evidence). For patients undergoing orthopedic
surgery or cardiac surgery and those with preexisting
Figure 4. The association of allogeneic blood transfusion and any infection in spine surgery.
Figure 5. Subgroup analysis comparing the association of allogeneic blood transfusion and surgical site infection (SSI) between spine surgery of
the lumbar and thoracic spines.
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cardiovascular disease, the AABB recommends a
restrictive RBC transfusion threshold (hemoglobin
level of 8 g/dL; strong recommendation, moderate
quality evidence). The restrictive hemoglobin transfu-
sion threshold of 7 g/dL is likely comparable to 8 g/dL,
but randomized controlled trial (RCT) evidence is not
available for all patient categories. These recommen-
dations apply to all but the following conditions for
which the evidence is insufficient for any recommen-
dation: acute coronary syndrome, severe thrombocyto-
penia (patients treated for hematological or oncological
disorders who at risk of bleeding), and chronic transfu-
sion–dependent anemia.
 Recommendation 2: The AABB recommends that
patients, including neonates, should receive RBC
units selected at any point within their licensed dat-
ing period (standard issue) rather than limiting
patients to transfusion of only fresh (storage length:
<10 days) RBC units (strong recommendation, mod-
erate quality evidence).
Discussion
We herein conducted a systematic review examining
(a) whether allogeneic blood transfusion increases the risk of
postoperative infection compared with no blood transfusion
and (b) whether there are any factors that modify the risk of
infection associated with allogeneic blood transfusion.
Addressing the first question, a body of very low
strength evidence showed mixed results for an association
between allogeneic blood transfusion and surgical site
infection. This may be a result of confounding factors that
are inherent to these different subgroups of patients, fac-
tors controlled for in some studies but not others. For
example, 3 studies reporting no significant association
controlled for American Society of Anesthesiologists
(ASA) class12-14 while 2 studies reporting a significant
association did not.7,8 The posterior approach has been
shown to be a risk factor for postoperative infection.17
Three studies in our review adjusted for approach7,12,14
whereas others did not.5,8,10,13,15
Two low-strength studies found a significant association
between allogeneic blood transfusion and UTI, yet no asso-
ciation was found between allogeneic blood transfusion
and RTI.7,8 The risk of any infection was significantly
associated with allogeneic blood transfusions, but again
with a very low strength of evidence.6,7 The significant
association between all infections and allogeneic blood
transfusions found by Fisahn et al6 was in a study popula-
tion of only 56 patients, the smallest population to yield
significant results in our series. When examining individ-
ual infection risks (eg, SSI, UTI) the association lost sig-
nificance. However, the underlying assumption of the
current clinical question is that allogeneic blood increases
infection risk because of its systemic immunomodulatory
effects. It is therefore appropriate to be pooling all post-
operative infections to examine for an association with
perioperative allogeneic transfusion.
Addressing the second question, a stratification of SSI data
by spine segment, lumbar and thoracic, found allogeneic blood
transfusion to be significantly associated with SSI in 3 of 4
studies in surgeries restricted to the lumbar spine. The
increased potential for infection in the lumbar region may be
due to its proximity to the perineal region, a significant poten-
tial source of infection.
Limitations
Studies included consisted only of low-quality retrospective
studies with high or moderately high risk of bias. These studies
are subject to confounding variables. In this review, every
study reporting both univariate and multivariate analyses had
important confounds as demonstrated by the large change in
the odds ratio between the 2 analyses. Because of the retro-
spective designs, not all studies collected the same prognostic
characteristics and potentially important information was
omitted, such as volume of blood transfused. Prospective stud-
ies are needed, which identify and control for all important
potential confounders for infection.
We estimate that 2400 patients will be needed in a prospec-
tive observational study to establish the relationship between
autologous blood transfusions and the risk of SSI assuming an
SSI risk of 2% in patients without transfusion, a power of 80%,
and an effect size of 2.0.
Table 3. Association (Adjusted Odds Ratio and 95% Confidence
Interval) Between Allogeneic Blood Transfusion and Infection in
Spine Surgery Stratified by Surgery Segment.
First Author Surgery Segment Adjusted OR (95% CI) P
SSI
Aoude 2016
Deep Lumbar only 2.4 (1.6-3.8) <.001
Superficial Lumbar only 1.5 (1.03-2.3) <.037
Janssen 2016 Lumbar only 2.6 (1.3 to 5.3) .007
Kato 2016 Lumbar only 1.9 (1.4-2.5) <.001
Woods 2013 Lumbar only 1.3 (0.5-2.9) .37
Aoude 2016
Deep Thoracic only 0.6 (0.1-3.0) .495
Superficial Thoracic only 0.9 (0.3-2.8) .914
Olsen 2008 Spinal Nonsignificant >.05
Maragakis 2009 Spinal Nonsignificant >.05
Olsen 2003 Spinal Nonsignificant >.05
Fisahn 2017 Spinal Not calculable –
Veeravegu 2009 Spinal 1.4 (1.1-1.9) <.05
UTI
Janssen 2015 Lumbar only 2.2 (1.3-3.8) .004
Kato 2016 Lumbar only 2.5 (1.5-4.2) <.001
RTI
Janssen 2015 Lumbar only 2.3 (0.96-5.3) >.05
Kato 2016 Lumbar only 1.1 (0.74-1.7) >.05
Any infection
Janssen 2015 Lumbar only 2.6 (1.7-3.9) <.001
Fisahn 2017 Spinal 3.5 (0.6-20.9) .172
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Conclusion
This systematic review failed to find a consistent association
between allogeneic transfusion and SSI in patients under-
going spinal surgery. However, the studies were all retrospec-
tive with a high or moderately high risk of bias. To understand
the nature of the association between allogeneic blood trans-
fusion and subsequent infection in spine surgery, appropri-
ately designed and controlled prospective studies of
sufficient power (n ¼ 2400) are required.
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